CardiOx Corp Closes $8M Series C Funding Round
Columbus, OH - August 31, 2011 - Heart test maker CardiOx Corp has announced the closing of an $8 million Series C funding round. Investments will support the company, which is developing a noninvasive device for detecting right-to-left heart shunts, through commercialization in the U.S. and Europe.
The round was led by Michigan-based Lifeline Ventures, a new investor in Columbus, Ohio-based CardiOx, and included contributions from existing investors Early Stage Partners, Glengary and Reservoir Partners, CardiOx CEO Larry Heaton said.
For the complete story click here.